Carcinoma, Ovarian Epithelial: all 1,619 studies
Page 6 of 17. Open to participants first (245), then studies with results posted, then the rest; newest registration first within each.
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube CancerStatus unknownNCT00108745Phase 3Results posted
- Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity CancerCompletedNCT00093496Phase 2Results posted
- Second-Line Treatment for Patients With Platinum-Sensitive Ovarian CancerCompletedNCT00090610Phase 2Results posted
- Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00083122Phase 2Results posted
- Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00072566Phase 2Results posted
- Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial CancerCompletedNCT00072410Phase 1Results posted
- Erlotinib Plus Carboplatin and Paclitaxel in Ovarian CarcinomaCompletedNCT00059787Phase 2Results posted
- A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian CancerCompletedNCT00058552Phase 2Results posted
- Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00053365Phase 2Results posted
- Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00041080Phase 3Results posted
- Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous ChemotherapyCompletedNCT00025155Phase 2Results posted
- Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00023712Phase 2Results posted
- Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00022659Phase 2Results posted
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00011986Phase 3Results posted
- S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian CancerCompletedNCT00008138Phase 2Results posted
- Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian CancerTerminatedNCT00006099Phase 1Results posted
- S9912 Combination Chemo in Stage III Ovarian Cancer,CompletedNCT00003896Phase 2Results posted
- Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian CancerCompletedNCT00003644Phase 3Results posted
- Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OCActive, not recruitingNCT07341100Phase 2
- O-RADS MRI System on Early Detection of Ovarian CancerActive, not recruitingNCT07009743
- NGS-based Germline and Somatic Genetic Test in Ovarian CarcinomaActive, not recruitingNCT06972693Phase 4
- SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal MetastasesActive, not recruitingNCT06940921Phase 1/2
- Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTOCompletedNCT06917469
- METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian CancerActive, not recruitingNCT06884345Phase 1/2
- Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer SurgeryCompletedNCT06879353Not applicable
- Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian CancerCompletedNCT06853730
- The Impact of the Inflammation Index on Predicting Postoperative Complications in Ovarian CancerCompletedNCT06798610
- Prediction of Platinum Resistance and Prognosis of High-grade Serous Ovarian CancerCompletedNCT06787170
- Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian CancerCompletedNCT06697613
- Agnostic Therapy in Rare Solid TumorsActive, not recruitingNCT06638931Phase 2
- Systemic Inflammatory Biomarkers in Ovarian CancerCompletedNCT06629831
- Improved Early Diagnosis in Female Pelvic Cancer With OC DetectCompletedNCT06613230
- Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated HypertensionActive, not recruitingNCT06515678
- A Biomarker Exploration Study of Precision Treatment in Ovarian CancerActive, not recruitingNCT06483425
- Research on Nutritional Risk Indexes and Inflammatory Indicators in Postoperative Complications and Prognosis of Epithelial Ovarian Cancer PatientsCompletedNCT06483399
- Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACTActive, not recruitingNCT06412510Phase 1/2
- Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian CancerWithdrawnNCT06393751Phase 1/2
- Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian CancerCompletedNCT06385912
- The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management ProgramCompletedNCT06379191Not applicable
- Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) TestCompletedNCT06366997
- Erdafitinib in Metastatic Steroid-cell Ovarian CancerCompletedNCT06328491Not applicable
- Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World SettingCompletedNCT06324734
- The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer ProgressionActive, not recruitingNCT06320418
- Clinical and Pathological Characteristics of Women With Ovarian Cancers in SyriaCompletedNCT06253559
- A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of ChemotherapyActive, not recruitingNCT06240598Phase 2
- RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal CancerCompletedNCT06173037Phase 2
- The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of LifeCompletedNCT06145295Not applicable
- First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive PatientsActive, not recruitingNCT06121401Phase 4
- Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination DeficiencyWithdrawnNCT06120972Phase 2
- A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT06087289Phase 1/2
- The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian CancerCompletedNCT06086665
- Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian CancerTerminatedNCT06068738
- Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid TumorsTerminatedNCT06065059Phase 1/2
- Health-Economic Evaluation of Early Diagnosis of Epithalial Ovarian Cancer Recurrence Using the ROMA Score: a Prospective Multicenter Randomized TrialWithdrawnNCT05991752Not applicable
- Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian CancerCompletedNCT05963334Phase 1/2
- Proteogenomic Signatures Analysis In Ovarian CancerActive, not recruitingNCT05953883Not applicable
- A Biomarker Screening Protocol for Participants With Solid TumorsTerminatedNCT05891197
- Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion ChemotherapyStatus unknownNCT05877911Phase 2
- REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1TerminatedNCT05870748Phase 2/3
- Retrospective Multicenter Study of Elderly Patients With Ovarian Cancer Treated With Trabectedin and PLDCompletedNCT05868889
- A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin AmericaActive, not recruitingNCT05857397
- The Efficacy and Safety of The Fuzuloparib Combination With BevacizumabStatus unknownNCT05819060Phase 2
- Individualized Precision Treatment Based on Ovarian Cancer Organoid ModelStatus unknownNCT05813509Not applicable
- NKG2D CAR-NK & Ovarian CancerStatus unknownNCT05776355Not applicable
- A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian CancerCompletedNCT05775549
- Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic EvaluationStatus unknownNCT05763472
- Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant ChemotherapyActive, not recruitingNCT05763199Phase 2
- Low Grade Serous Ovarian Carcinoma and Uterine Involvement : Should Hysterectomy be the RuleCompletedNCT05741554
- Oral Topotecan Combined With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian CancerWithdrawnNCT05736952Phase 2
- Effectiveness and Safety of Niraparib as First-line Maintenance Therapy for Ovarian Cancer: a Real-world StudyCompletedNCT05734911
- PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian CarcinomaWithdrawnNCT05714306Phase 1/2
- Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid TumorsCompletedNCT05700669Phase 1/2
- Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)Status unknownNCT05693987
- Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)Status unknownNCT05693974
- Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian CancerWithdrawnNCT05672095Phase 1/2
- Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance TherapyStatus unknownNCT05669768Phase 2
- MicroFluO: FLUorescence-guided Surgery for Ovarian CancerCompletedNCT05633836Not applicable
- A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian CancerStatus unknownNCT05622890Phase 3
- A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With CisplatinStatus unknownNCT05620654Phase 1
- Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerActive, not recruitingNCT05620134Phase 1/2
- AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian CancerActive, not recruitingNCT05617755Phase 1
- Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsCompletedNCT05585034Phase 1
- Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian CarcinomaStatus unknownNCT05576519
- Role of Laparoscopy in Assessing Resectability of Ovarian CancerCompletedNCT05564234Not applicable
- 89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsTerminatedNCT05563272Phase 2
- A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersActive, not recruitingNCT05544929Phase 1
- Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian CancerStatus unknownNCT05523804
- Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to PlatinumCompletedNCT05512676
- Detection of Circulating Tumor DNA Through Liquid Biopsies in Ovarian Cancer Patients and Evaluation of Prognostic and Predictive Values of Circulating Tumor DNA Assay.CompletedNCT05504174
- Ovarian Cancer Individualized Scoring System Scoring SystemStatus unknownNCT05496517
- Role of the ATP7A Transporter in Ovarian CancerCompletedNCT05490407Not applicable
- A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor ExposureActive, not recruitingNCT05489926Phase 2
- A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP InhibitorActive, not recruitingNCT05475184Phase 2
- Genetic Testing Decision AidCompletedNCT05470920Not applicable
- Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.Status unknownNCT05458973
- Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian CancerStatus unknownNCT05422183Phase 2
- Intraperitoneal Chemotherapy Versus Triweekly ChemotherapyCompletedNCT05410938
- A Study of NI-1801 in Patients with Mesothelin Expressing Solid CancersStatus unknownNCT05403554Phase 1
- ITIL-306 in Advanced Solid TumorsTerminatedNCT05397093Phase 1
- A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPiStatus unknownNCT05385068Phase 2